The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zviagin A.A.

Institut khirurgii im. A.V. Vishnevskogo Ministerstva zdravookhraneniia i sotsial'nogo razvitiia RF, Moskva

Demidova V.S.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Smirnov G.V.

Vishnevsky National Medical Research Center for Surgery of Healthcare Ministry of Russia, Moscow, Russia

Sepsis biomarkers dynamics as an indicator of intensive care effectiveness

Authors:

Zviagin A.A., Demidova V.S., Smirnov G.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2019;(2): 53‑57

Read: 1449 times


To cite this article:

Zviagin AA, Demidova VS, Smirnov GV. Sepsis biomarkers dynamics as an indicator of intensive care effectiveness. Pirogov Russian Journal of Surgery. 2019;(2):53‑57. (In Russ.)
https://doi.org/10.17116/hirurgia201902153

Recommended articles:
Open-access data­bases in anesthesiology and inte­nsive care: a systematic review and guidelines. Russian Journal of Anesthesiology and Reanimatology. 2025;(4):61-71

References:

  1. Qi Zou, Wei Wen, and Xin-chao Zhang. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16-19. https://doi.org/10.5847/wjem.j.issn.1920-8642.2014.01.002
  2. Jawad I, Luksic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Global Health. 2012;2:1-9. https://doi.org/10.7189/jogh.01.010404
  3. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti-Infect Ther. 2012;10:701-706. https://doi.org/10.1586/eri.12.50
  4. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8). https://doi.org/10.1001/jama.2016.0287
  5. Fan SL, Miller NS, Lee J, Remick DG. Diagnosing sepsis: the role of laboratory medicine. Clin Chim Acta. 2016;460:203-210. https://doi.org/10.1016/j.cca.2016.07.002
  6. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486-552. https://doi.org/10.1097/CCM.0000000000002255
  7. De Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819-827. https://doi.org/10.1016/S1473-3099(16)00053-0
  8. Ali FT, Ali MA, Elnakeeb MM, Bendary HN. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis. Clin Chim Acta. 2016;460:93-101. https://doi.org/10.1016/j/cca.2016.06.030
  9. Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueckmann M, et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care. 2014;18:507. https://doi.org/10.1186/s13054-014-0507-z
  10. Klouche K, Cristol JP, Devin J, Gilles V, Kuster N, Larcher R, et al. Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care. 2016;6:59. https://doi.org/10.1186/s13613-016-0160-6
  11. Julian-Jimenez A, Candel-Gonzalez FJ, Gonzalez Del Castillo J. Usefulness of inflammation and infection biomarkers in the Emergency Department. Enferm Infecc Microbiol Clin. 2014;32(3):177-190. https://doi.org/10.1016/j.eimc.2013.01.005
  12. Cakir Madenci O, Yakupoglu S, Benzonana N, Yucel N, Akbaba D, Orcun Kaptanagasi A. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns. 2014;40(4):664-669. https://doi.org/10.1016/j.burns.2013.08.024
  13. Carpio R, Zapata J, Spanuth E, Hess G. Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department. Clin Chim Acta. 2015;450:169-175. https://doi.org/10.1016/j.cca.2015.08.013
  14. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891-897. https://doi.org/10.1007/s10156-012-0435-2
  15. Godnic M, Stubljar D, Skvarc M, Jukic T. Diagnostic and prognostic value of sCD14-ST-presepsin for patients admitted to hospital intensive care unit (ICU). Wien Klin Wochenschr. 2015;127(13-14):521-527. https://doi.org/10.1007/s00508-015-0793-8
  16. Ishikura H, Nishida T, Murai A, Nakamura Y, Irie Y, Tanaka J, Umemura T. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Crit Care. 2014;18(1):R19. https://doi.org/10.1186/cc13700
  17. Kweon OJ, Choi JH, Park SK, Park AJ. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. J Crit Care. 2014;29(6):965-970. https://doi.org/10.1016/j.jcrc.2014.06.014
  18. Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013;17(5):R244. https://doi.org/10.1186/cc13070
  19. Sepsis: klassifikatsiya, kliniko-diagnosticheskaya kontseptsiya i lechenie. Pod redaktsiei akad. RAN Gel’fanda BR. M.: MIA; 2017;351. (In Russ.)
  20. Velkov VV. Presepsin — new highly effective sepsis biomarker. Kliniko-laboratornyi konsilium. Nauchno-prakticheskii zhurnal. 2012;2(42):56-62. (In Russ.)
  21. Demidova VS, Ushakova TA, Zvyagin AA, Bobrovnikov AE, Medova OV, Koryakov IA. The clinical significance of presepsine in infectious complications in patients with surgical infection and burn trauma. Infektsii v khirurgii. 2014;4:44-46. (In Russ.)
  22. Gel’fand BR, Protsenko DN, Gel’fand EB, Yaroshetskii AI. Sepsis: patogenez i sovremennye metody intensivnoi terapii. Rukovodstvo po ekstrakorporal’nomu ochishcheniyu krovi v intensivnoi terapii. M. 2009;273-299 (In Russ.)
  23. Gel’fand BR, Burnevich SZ, Gel’fand EB, Brazhnik TB, Sergeeva NA. Biokhimicheskie markery sistemnoi vospalitelnoy reaktsii: rol’ prokal;tsitonina v diagnostike sepsisa. Infektsii v khirurgii. 2007;5(1):17-24. (In Russ.)
  24. Velkov VV. Procalcitonin and c-reactive protein in modern laboratory diagnostics. Part 2. Kliniko-laboratornyi konsilium. Nauchno-prakticheskii zhurnal. 2009:34-38. (In Russ.)
  25. Vodnik T, Kaljevic G, Tadic T, Majkic-Singh N. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis. Clin Chem Lab Med. 2013;51:2053-2062. https://doi.org/10.1515/cclm-2013-0061

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.